Kan Chen

Kan Chen

Plus aucun poste en cours
44 ans
Health Technology
Consumer Services

Profil

Kan Chen is currently a Non-Executive Director at LongBio Pharma (Suzhou) Co., Ltd. and Ming Yu Pharmaceutical Ltd., both starting in 2025.
Former positions include Director at Jiangsu Yahong Meditech Co., Ltd. from 2020 to 2023; Non-Executive Director at Antengene Corp.
Ltd. from 2021 to 2024; Non-Executive Director at Abbisko Cayman Ltd. from 2020 to 2021; Non-Executive Director at CANbridge Pharmaceuticals Inc. from 2020 to 2024; Non-Executive Director at Connect Biopharma Holdings Ltd. from 2020 to 2025; and Non-Executive Director at InSilico Medicine Cayman TopCo from 2023 to 2026.
Education includes a doctorate from Harvard Medical School conferred in 2012, a doctorate from Case Western Reserve University conferred in 2009, and an undergraduate degree from Fudan University conferred in 2004.

Postes actifs de Kan Chen

SociétésPosteDébut

Anciens postes connus de Kan Chen

SociétésPosteFin
INSILICO MEDICINE CAYMAN TOPCO Directeur/Membre du Conseil 15/07/2026
CONNECT BIOPHARMA HOLDINGS LIMITED Directeur/Membre du Conseil 01/12/2025
CANBRIDGE PHARMACEUTICALS INC. Directeur/Membre du Conseil 01/09/2024
ANTENGENE CORPORATION LIMITED Directeur/Membre du Conseil 01/06/2024
JIANGSU YAHONG MEDITECH CO., LTD. Directeur/Membre du Conseil 01/12/2023
Voir l'expérience en détail de Kan Chen

Formation de Kan Chen

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

96

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées9

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

🔇